Frontiers In Precision Medicine for Inherited Cancers: From Risk Assessment to Targeted Therapies

Chicago, IL US
April 20, 2018 to April 21, 2018
This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science including novel therapies for inherited cancers, discuss real-world cases, curate interesting pedigrees and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members.
 
Click on the "Get Started!" tab to register!
 

This activity is brought to you in partnership with City of Hope. 

Learning Objectives and Target Audience

At the conclusion of this activity, participants will be able to:

  • Identify how advanced concepts in genetics, genomics, and next generation sequencing (NGS) technologies can be applied to patient care;
  • Recognize advances in the clinical management of patients with inherited cancer syndromes including breast, prostate, gastrointestinal, and hematologic malignancies;
  • Discuss integration of novel cancer therapies based on genomic alterations in tumor tissue that may reveal germline mutations such as MLH1 and BRCA mutations into the practice of oncology;
  • Describe how to manage cancer patients from high risk families using a globally-informed perspective;
  • Discuss emerging models for cancer risk assessment and genetic testing including integration of a polygenic risk score;
  • Recognize the ethical, legal, and social implications of genomic testing in healthy populations.
This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their healthcare system. Special efforts will be made to educate clinicians practicing in geographically or socioeconomically underserved communities.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Polly Grieger-Rossi
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
219-465-1115
Summary
Available credit: 
  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 Participation
  • 15.00 Genetic Counseling CEU
Event starts: 
04/20/2018 - 7:30am
Event ends: 
04/21/2018 - 5:30pm
Activity opens: 
07/02/2017
Activity expires: 
07/21/2018

The Gwen, a Luxury Collection Hotel, Chicago
521 North Rush Street
Chicago, IL 60611
United States
SPECIAL ATTENDEE RATES AVAILABLE
Due to the overwhelming popularity of the course, we have sold out of the room block at the host hotel, The Gwen.
The conference however has secured rooms at the Chicago Marriott Downtown Magnificent Mile for the same $185 per night rate.
 

TRAVEL AWARDS
Funds are available for merit- and need-based travel awards for individuals submitting an abstract for poster presentation and/or submission of interesting pedigrees to include in the conference proceedings. Trainees in genetic counseling, nursing or clinical oncology training programs and junior faculty members are encouraged to apply for travel awards. Potential recipients for need-based awards are reviewed for eligibility by the organizing committee based both on:
 
  • His or her representatives as an underrepresented minority health professional, and/or on the applicant’s provision of genetic cancer risk assessment services to underserved and underrepresented minority patient populations
  • Statement of limited or no institutional funding for attendance.
Submissions are due March 20, 2018.

APPLY

 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Polly Grieger-Rossi at 219-465-1115 or via email at polly@meetingachievments.com

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

CONFERENCE CO-DIRECTORS
  Olufunmilayo Falusi Olopade, MBBS, FACP
  Walter L. Palmer Distinguished Service Professor
  Director, Center for Clinical Cancer Genetics
  Departments of Medicine and Human Genetics
  University of Chicago Medicine

  Iris Romero, MD
  Associate Professor of Obstetrics & Gynecology
  Associate Director, Center for Clinical Cancer Genetics
  University of Chicago Medicine
 
 
  Kathy Blazer, EdD, MS, LCGC
  Associate Director, Cancer Genetics Education Program
  City of Hope National Medical Center
 
 

  Jeffrey N. Weitzel, MD
  Chief, Clinical Cancer Genetics
  Professor of Oncology and Population Sciences
  City of Hope National Medical Center
 
 
INTERNATIONAL GUEST FACULTY
Roslind Eeles FMedSci, PhD, FRCP, FRCR
Professor of Oncogenetics
The Institute of Cancer Research
Sutton, United Kingdom
William Foulkes, MBBS, PhD, FRSC
Director, Program in Cancer Genetics
McGill University
Montreal, Quebec
Kelly Metcalfe, RN, PhS, FAAN
Professor in Cancer Genetics
Lawrence S. Bloomberg Faculty of Nursing
University of Toronto
Toronto, Ontario
Rajiv Sarin, MD
Director ACTREC
Tata Memorial Centre
Mumbai, India
GUEST FACULTY
Stephen Chanock, MD
Director, Division of Cancer Epidemiology and Genetics
National Cancer Institute
Susan Hong, MD
Associate Professor of Medicine
Director of Cancer Survivorship
University of Illinois in Chicago
Kutluk Oktay, MD, PhD
Professor of OB/GYN and Reproductive Sciences
Yale University
Laurie M. Connors, DNP, APNG, FNP-BC, AGN-BC
Assistant Professor
School of Nursing/Clinical and Translational Hereditary Cancer Program
Vanderbilt University
Marshall Horwitz, MD, PhD
Professor & Associate Dean
University of Washington
Jodyn Platt, MPH, PhD
Assistant Professor of Learning Health Sciences
University of Michigan
Susan Domchek, MD
Basser Professor of Oncology
University of Pennsylvania
Steven Lipkin, MD, PhD, FACMG
Director, Program in Mendelian Genetics
Director, Adult and Cancer Genetics Clinic
Weill Cornell Medicine
Colin Pritchard, MD, PhD
Associate Professor, Laboratory Medicine
Director, Genetics and Solid Tumors Laboratory
University of Washington
Montserrat Garcia-Closas, MD, DrPH
Deputy Director
Division of Cancer Epidemiology and Genetics
National Cancer Institute
Arthur Lupia, PhD
Hal R Varian Collegiate Professor
University of Michigan
Timothy Rebbeck, PhD
Professor
Harvard Chan School & Dana Farber Cancer Institute
Michael Hall, MD, MS
Director, Gastrointestinal Cancer Risk Assessment Program
Associate Professor of Medicine
Department of Clinical Genetics
Fox Chase Cancer Center
Kara Milliron, MS, CGC
Genetic Counselor
Hematology/Oncology
University of Michigan Comprehensive Cancer Center
Jorge Reis-Filho, MD, PhD
Chief, Experimental Pathology Service
Member and Attending Pathologist
Memorial Sloan Kettering Cancer Center
Heather Hampel, MS, LGC
Professor of Internal Medicine
Associate Director, Division of Human Genetics
The Ohio State University
Elias Obeid, MD, MPH
Director, Prostate Cancer Risk Assessment Program
Assistant Professor
Fox Chase Cancer Center
Dawn Sinclair Shapiro
Film Director
THE UNIVERSITY OF CHICAGO FACULTY
Andrea Amico, MD, MA
Clinical Associate
Hematology/Oncology
Valerie Koch, JD
Director, Law & Ethics
MacLean Center for Clinical Medical Ethics
Blase Polite, MD, MPP
Associate Professor
Executive Medical Director for Cancer Accountable Care
Hematology/Oncology & Center for Clinical Cancer Genetics
Jane Churpek, MD
Assistant Professor
Hematology/Oncology & Center for Clinical Cancer Genetics
Sonia Kupfer, MD
Assistant Professor of Medicine
Director Gastrointestinal Cancer Risk & Prevention Clinic
Iris Romero, MD
Associate Professor
Department of Obstetrics & Gynecology
Dean for Diversity
Michael Drazer, MD
Fellow
Hematology/Oncology
Sarah Nielsen, MS, CGC
Cancer Genetic Counselor
Shari Snow, MD
Assistant Professor of Obstetrics/Gynecology
Section Chief, Gynecology and Minimally Invasive Surgery
Scott Eggener, MD
Associate Professor of Urology – Urologic Oncology and Radiology
Urology
Olufunmilayo Olopade, MD, FACP
Professor of Medicine
Director, Center for Clinical Cancer Genetics
Randy Sweis, MD
Instructor of Medicine
Hematology/Oncology
Lucy Godley, MD, PhD
Professor of Medicine
Hematology/Oncology
Aytekin Oto, MD, MBA
Professor of Radiology
Caroline Weipert, MS, CGC
Cancer Genetic Counselor
Neil Hyman, MD, FACS
Professor of Surgery
Section Chief, Colon and Rectal Surgery
Melody Perpich, MS, CGC
Genetic Counselor
Pediatric Oncology
Allison West, MD
Fellow
Hematology/Oncology

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 1.5 CEUs or 15.0 Category 1 contact hours for the activity 7th Annual Clinical Cancer Genetics and Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
 
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Accreditation Period

Activity opens: 
07/02/2017
Activity expires: 
07/21/2018
REGISTRATION: Select your profession type and click "Register Now!" Simply follow the prompts to complete your registration.
For more information, view the brochure here.
Early Bird Rate: Use the EARLY BIRD CODE listed with YOUR PROFESSION TYPE to access the early bird rate.
Early Bird ends March 16, 2018!

 
Profession TypeEarly BirdEarly Bird CodeRegular
Physicians$495EXPIRED$595
Genetic Counselors
*$25 additional fee for Genetic Counseling CEUs
$300EXPIRED$345
Other Healthcare Professionals$300EXPIRED$345
Resident/Fellow - Letter of Verification Required Send here
$195EXPIRED$275

 
CCGCoP members: To receive a $50 per person discount - please enter CCGC50 to receieve the discount.

Genetic Counselors: Select the "Genetic Counseling CEU Fee" in addition to your registration fee if you would like to claim Genetic Counseling CEUs.

 
CLAIMING CREDIT: At the end of the course, the credit claiming process will unlock. Return to this page and simply click on "Complete Activity" to proceed.

CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $100 administrative fee will be refunded when written notification is received by March 20, 2018. No refunds will be made after March 20, 2018.


Please Note: We are close to reaching capacity.
At capacity, registration will close and the waitlist will open to which you may add yourself.
However, you must be logged in or have created an account to do so.
Please login or create an account to proceed.